ATE223926T1 - Verfahren zur herstellung von igf-1 und igfbp-3 mit richtiger faltung und disulfidbindungen - Google Patents

Verfahren zur herstellung von igf-1 und igfbp-3 mit richtiger faltung und disulfidbindungen

Info

Publication number
ATE223926T1
ATE223926T1 AT96916829T AT96916829T ATE223926T1 AT E223926 T1 ATE223926 T1 AT E223926T1 AT 96916829 T AT96916829 T AT 96916829T AT 96916829 T AT96916829 T AT 96916829T AT E223926 T1 ATE223926 T1 AT E223926T1
Authority
AT
Austria
Prior art keywords
igfbp
igf
disulfide bonds
proper folding
cofolding
Prior art date
Application number
AT96916829T
Other languages
English (en)
Inventor
Andreas Sommer
Yasushi Ogawa
Peggy Tao
Original Assignee
Celtrix Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Celtrix Pharma filed Critical Celtrix Pharma
Application granted granted Critical
Publication of ATE223926T1 publication Critical patent/ATE223926T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • C07K1/113—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure
    • C07K1/1133—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure by redox-reactions involving cystein/cystin side chains
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4743—Insulin-like growth factor binding protein
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/65—Insulin-like growth factors, i.e. somatomedins, e.g. IGF-1, IGF-2
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Analytical Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Endocrinology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Physics & Mathematics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Compounds Of Unknown Constitution (AREA)
AT96916829T 1995-06-07 1996-05-30 Verfahren zur herstellung von igf-1 und igfbp-3 mit richtiger faltung und disulfidbindungen ATE223926T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/482,271 US5789547A (en) 1995-06-07 1995-06-07 Method of producing insulin-like growth factor-I (IGF-I) and insulin-like growth factor binding protein-3 (IGFBP-3) with correct folding and disulfide bonding
PCT/US1996/008113 WO1996040736A1 (en) 1995-06-07 1996-05-30 Method of producing igf-i and igfbp-3 with correct folding and disulfide bonding

Publications (1)

Publication Number Publication Date
ATE223926T1 true ATE223926T1 (de) 2002-09-15

Family

ID=23915418

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96916829T ATE223926T1 (de) 1995-06-07 1996-05-30 Verfahren zur herstellung von igf-1 und igfbp-3 mit richtiger faltung und disulfidbindungen

Country Status (15)

Country Link
US (1) US5789547A (de)
EP (1) EP0832098B1 (de)
JP (1) JPH11507037A (de)
KR (1) KR19990022718A (de)
CN (1) CN1214689A (de)
AT (1) ATE223926T1 (de)
AU (1) AU703489B2 (de)
CA (1) CA2223495A1 (de)
CZ (1) CZ394397A3 (de)
DE (1) DE69623620T2 (de)
DK (1) DK0832098T3 (de)
ES (1) ES2179943T3 (de)
NO (1) NO975749L (de)
PL (1) PL323731A1 (de)
WO (1) WO1996040736A1 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6015786A (en) * 1997-02-25 2000-01-18 Celtrix Pharmaceuticals, Inc. Method for increasing sex steroid levels using IGF or IGF/IGFBP-3
US6025368A (en) * 1997-02-25 2000-02-15 Celtrix Pharmaceuticals, Inc. Method for treating the symptoms of chronic stress-related disorders using IGF
US6514937B1 (en) 1997-02-25 2003-02-04 Celtrix Pharmaceuticals, Inc. Method of treating psychological and metabolic disorders using IGF or IGF/IGFBP-3
US5914390A (en) * 1997-05-12 1999-06-22 Celtrix Pharmaceuticals, Inc. Methods for increasing yields of recombinant proteins
US6653098B1 (en) * 1998-02-23 2003-11-25 G. D. Searle & Co. Method of producing mouse and human endostatin
US6417330B1 (en) 1998-06-01 2002-07-09 Celtrix Pharmaceuticals, Inc. Insulin-like growth factor binding protein variants
US6436897B2 (en) 1998-06-01 2002-08-20 Celtrix Pharmaceuticals, Inc. Pharmaceutical formulations for IGF/IGFBP
EP1273655A4 (de) * 2000-03-30 2004-08-04 Takeda Chemical Industries Ltd Verfahren zur herstellung eines rekombinanten proteins
EP1399475A2 (de) * 2001-06-07 2004-03-24 F. Hoffmann-La Roche Ag Mutanten igf-bindender proteine und verfahren zur produktion deren antagonisten
ES2341270T3 (es) * 2004-12-24 2010-06-17 Insmed, Inc. Complejos rhigf-i/rhigfbp-3 purificados y procedimientos de fabricacion de los mismos.
US8518877B2 (en) 2007-04-18 2013-08-27 Premacure Ab Method and product for treatment and/or prevention of complications of prematurity
CN104011070A (zh) * 2011-12-15 2014-08-27 爱德迪安（北京）生物技术有限公司 具有降血糖作用的化合物、组合物及其用途
EA202090705A1 (ru) 2017-09-11 2020-06-11 Шайр Хьюман Дженетик Терапиз, Инк. Способы и композиции, предназначенные для лечения хронических заболеваний легких
CN107991492A (zh) * 2017-11-17 2018-05-04 广州赛莱拉干细胞科技股份有限公司 一种胰岛素样生长因子结合蛋白-3的定量检测试剂盒及其非诊断目的的检测方法
CN111876490B (zh) * 2020-07-03 2022-07-15 扬州大学 一种提高猪生长速度的连锁分子标记、其检测方法及应用
IL301688A (en) 2020-10-19 2023-05-01 Oak Hill Bio Ltd The compositions are suitable for use in newborns
IL314331A (en) 2022-01-19 2024-09-01 Oak Hill Bio Ltd Methods and compounds for reducing oxidation of IGF-1/IGFBP
WO2023139250A1 (en) * 2022-01-24 2023-07-27 Oak Hill Bio Limited Lot release assays for igf‐1/igfbp complexes

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4511503A (en) * 1982-12-22 1985-04-16 Genentech, Inc. Purification and activity assurance of precipitated heterologous proteins
US4512922A (en) * 1982-12-22 1985-04-23 Genentech, Inc. Purification and activity assurance of precipitated heterologous proteins
US4511502A (en) * 1982-12-22 1985-04-16 Genentech, Inc. Purification and activity assurance of precipitated heterologous proteins
IL71991A (en) * 1983-06-06 1994-05-30 Genentech Inc Preparation of human FGI and FGE in their processed form through recombinant AND tranology in prokaryotes
US4766205A (en) * 1985-11-13 1988-08-23 Beatrice Companies, Inc. Method for isolation of recombinant polypeptides in biologically active forms
US5258287A (en) * 1988-03-22 1993-11-02 Genentech, Inc. DNA encoding and methods of production of insulin-like growth factor binding protein BP53
US5158875A (en) * 1989-08-25 1992-10-27 Amgen Inc. Production of biologically active insulin-like growth factor i from high expression host cell systems
US5288931A (en) * 1991-12-06 1994-02-22 Genentech, Inc. Method for refolding insoluble, misfolded insulin-like growth factor-I into an active conformation
AU3812993A (en) * 1992-03-24 1993-10-21 Synergen, Inc. Refolding and purification of insulin-like growth factor I
SE9303784D0 (sv) * 1993-11-16 1993-11-16 Kabi Pharmacia Ab Igf

Also Published As

Publication number Publication date
DE69623620T2 (de) 2003-08-07
DE69623620D1 (de) 2002-10-17
EP0832098B1 (de) 2002-09-11
EP0832098A1 (de) 1998-04-01
EP0832098A4 (de) 1999-09-15
ES2179943T3 (es) 2003-02-01
NO975749L (no) 1998-01-27
AU5957696A (en) 1996-12-30
DK0832098T3 (da) 2002-12-16
JPH11507037A (ja) 1999-06-22
CN1214689A (zh) 1999-04-21
WO1996040736A1 (en) 1996-12-19
NO975749D0 (no) 1997-12-05
KR19990022718A (ko) 1999-03-25
CZ394397A3 (cs) 1998-09-16
PL323731A1 (en) 1998-04-14
AU703489B2 (en) 1999-03-25
US5789547A (en) 1998-08-04
CA2223495A1 (en) 1996-12-19

Similar Documents

Publication Publication Date Title
ATE223926T1 (de) Verfahren zur herstellung von igf-1 und igfbp-3 mit richtiger faltung und disulfidbindungen
ES2058341T3 (es) Subunidades de proteina portadoras de somatomedina humana y proceso para producirlas.
DE59305396D1 (de) Verfahren zur Gewinnung von Proinsulin mit korrekt verbundenen Cystinbrücken
DK564989D0 (da) Bindingsproteiner
PL323858A1 (en) Compounds and peptides capable to bond to a receptor of erythropoetin
ATE329624T1 (de) Technetium-99m markierte peptide zur bilderzeugung von thrombus
ATE352617T1 (de) Lösliche polypeptidfraktionen des lag-3-proteins; verfahren zur herstellung; therapeutische zusamensetzung; antiidiotypischer antikörper
ATE181320T1 (de) Verfahren zur herstellung von mischungen von n- acylierten aminosaeuren
IL92816A0 (en) Recombinant dna molecules,hosts,processes and human somatomedin carrier protein-like polypeptides
ATE350053T1 (de) Herstellung von humaninsulin
DE3676683D1 (de) Mischung von derivaten von aminosaeuren, verfahren zur herstellung der mischung und verwendung der mischung zur mengenbestimmung der aminosaeuren.
DE69319012D1 (de) Protein mit Knochenbildungs-Eigenschaften und Verfahren zu seiner Herstellung
WO1995032221A3 (en) Autotaxin: motility stimulating protein useful in cancer diagnosis and therapy
DE69508532D1 (de) Markierungsmaterial für Treibriemen und ein Verfahren zur Herstellung von Treibriemen mit diesem Markierungsmaterial
ATE177459T1 (de) Verfahren zur kontinuierlichen herstellung von flüssigsiliconkautschuken
ATE212360T1 (de) Polyethylenglycol-hirudin-konjugate, deren verfahren zur herstellung und verwendung für die heilung von thrombosen
ATE194167T1 (de) Ein prozess für die herstellung von faktor ix biologischen ursprungs
DE59605774D1 (de) Verfahren zur Herstellung von beta-Carotin-Präparaten mit hohem 9(Z)-Gehalt
ATE161269T1 (de) Verfahren zur herstellung von peptiden und neue zwischenverbindungen dazu
ATE81013T1 (de) Verfahren zur herstellung von faktor viii:cmangelplasma und ein so erhaltenes mangelplasma.
ATE190653T1 (de) Verfahren zur herstellung von rekombinanten und synthetischen peptiden und deren verwendung
DE69423516D1 (de) Verwendung von igf-bp zur rückfaltung von igf
PT959895E (pt) Peptidos que reajem a anticorpos contra um peptido de consenso da familia de proteinas cs4-cfa/i
DE69608512D1 (de) Verfahren zur Herstellung von benzylsubstituierten Rhodaninederivaten
ATE253839T1 (de) Verfahren zur herstellung von molkenproteinaggregaten aus sauermolke

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0832098

Country of ref document: EP

REN Ceased due to non-payment of the annual fee